Results 231 to 240 of about 42,544 (264)

Fecal microbiota transplantation induces hepatitis B virus e‐antigen (HBeAg) clearance in patients with positive HBeAg after long‐term antiviral therapy

Hepatology, 2017
Yan-Dan Ren, Zhen-shi Ye, Liu‐Zhu Yang, Li-Xin Jin, Wen-Jun Wei, Yong Deng, Xiao‐Xiao Chen, C. xiao, Xiao-Fang Yu, Hong‐zhi Xu, Lizhe Xu, Yunna Tang, Fei Zhou, Xue-Lian Wang, Mei-ya Chen, Ligang Chen, Mei-Zhu Hong, Jian‐lin Ren, Jin-Shui Pan   +18 more
semanticscholar   +1 more source

Increase risk of HBeAg-negative chronic hepatitis B with older age at HBeAg seroconversion

2010
Background: Recent evidence suggests that delayed HBeAg seroconversion is associated with poorer outcome. We aim to determine the incidence of HBeAg-negative chronic hepatitis B (CHB) according to the age at which HBeAg seroconversion occurs. Methods: Chronic hepatitis B patients with natural HBeAg seroconversion and over 12 months follow-up after ...
Fung, JYY, Lai, CL, Wong, DKH, Yuen, JCH, Yuen, RMF   +4 more
openaire   +2 more sources

DARING-B: Discontinuation of Effective Entecavir or Tenofovir Disoproxil Fumarate Long-Term Therapy before HBsAg Loss in Non-Cirrhotic HBeAg-Negative Chronic Hepatitis B

Antiviral Therapy, 2018
G. Papatheodoridis, E. Rigopoulou, M. Papatheodoridi, K. Zachou, V. Xourafas, N. Gatselis, E. Hadziyannis, J. Vlachogiannakos, S. Manolakopoulos, G. Dalekos   +9 more
semanticscholar   +1 more source

Ultrasensitive electrochemical immunosensor for quantitative detection of HBeAg using Au@Pd/MoS2@MWCNTs nanocomposite as enzyme-mimetic labels.

Biosensors & bioelectronics, 2018
Zengqiang Gao, Yueyun Li, Xiaobo Zhang, Jinhui Feng, Ling Kong, Ping Wang, Zhiwei Chen, Yun-hui Dong, Qin Wei   +8 more
semanticscholar   +1 more source

On-treatment decline in HBeAg level at week 24 predicts for HBeAg seroconversion during long-term tenofovir therapy for HBeAg-positive CHB

Journal of Hepatology, 2017
D. Wong, M. Littlejohn, L. Yuen, K. Jackson, H. Mason, A. Gaggar, K. Kitrinos, M. Subramanian, P. Marcellin, M. Buti, H. Janssen, E. Gane, J. Bayliss, V. Sozzi, D. Colledge, S. Locarnini, A. Thompson, P. Revill   +17 more
openaire   +1 more source

Higher HBeAg‐reversion virological relapse and lower sustained remission after treatment cessation in tenofovir‐treated HBeAg‐positive patients

Journal of Medical Virology, 2023
Yi-Cheng Chen
exaly  

No detectable resistance to tenofovir disoproxil fumarate in HBeAg+ and HBeAg− patients with chronic hepatitis B after 8 years of treatment

Journal of Viral Hepatitis, 2017
Yang Liu, A. Corsa, M. Buti, A. Cathcart, John F Flaherty, M. Miller, K. Kitrinos, P. Marcellin, E. Gane   +8 more
semanticscholar   +1 more source

Comparison of the Antigenicity and Protein Composition of Hepatitis B Virus e Antigen Subtypes HBeAg/1 and HBeAg/2

Journal of General Virology, 1983
Hitoshi Ohori, H Ohori
exaly  

HBeAg

2009
openaire   +1 more source

Immunological and Morphological Properties of HBeAg Subtypes (HBeAg/1 and HBeAg/2) in Hepatitis B Virus Core Particles

Journal of General Virology, 1984
Hitoshi Ohori, H Ohori
exaly